Citation Tools
PDFClinical pharmacy and clinical trials (including case series)
CPC-091 Natalizumab in Cypriot Patients with Relapsing Remitting Multiple Sclerosis: Three Year Data on Safety, Efficacy and Frequency of Anti-JC Virus Antibodies
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- CPC-091 Natalizumab in Cypriot Patients with Relapsing Remitting Multiple Sclerosis: Three Year Data on Safety, Efficacy and Frequency of Anti-JC Virus Antibodies